8 interventions in Diagnostic.
ApoB (Apolipoprotein B)
One of the few longevity-community favorites that is genuinely well-founded: causality is established by genetics and trials, and ApoB meaningfully improves risk assessment over LDL-C, especially in metabolically abnormal people. Not hype. The main gap is that guideline adoption and outcome-defined ApoB targets are still catching up to the mechanistic case.
Inflammatory Markers (hsCRP)
A validated, inexpensive marker of the inflammaging that underlies much age-related disease, with genuine causal backing from CANTOS. Its limitation is nonspecificity: a single high hsCRP can reflect a cold or extra body fat rather than aging, so it is a trend tool, not a precise aging readout.
Composite Biological Age Blood Tests (PhenoAge)
A cheap, well-validated way to summarize routine labs into a mortality-predictive biological age, more accessible than epigenetic clocks. But it predicts risk; it does not prove that pushing the number down extends life, and the DTC market layers marketing and unvalidated variants on top of the sound core method.
Epigenetic Clocks (Horvath, GrimAge, DunedinPACE)
The best surrogate we have for biological aging and genuinely predictive of outcomes. But a clock reading is a prediction, not a proven modifiable target: no one has shown that lowering your GrimAge with a supplement makes you live longer. Treat them as research-grade risk indicators, not a scoreboard to game.
Frailty Index
One of the most clinically validated, decision-relevant measures of biological aging, quietly outperforming trendier tests, but it is most informative in older adults and is a status marker rather than something you directly 'lower.' Underused in longevity circles that prefer novel biomarkers over this robust standby.
Glucose Monitoring / CGM
Glucose control is unquestionably important for aging, and testing HbA1c/fasting glucose is standard good medicine. But strapping a CGM on a healthy person to chase flat curves is a wellness trend running well ahead of evidence: postprandial spikes are normal, devices are noisy, and no outcome data support it. Valuable for dysglycemia, oversold for the worried well.
Grip Strength
A remarkably powerful, dirt-cheap prognostic marker that outperforms blood pressure for mortality prediction. Its limitation is that it is a marker, not a lever: squeezing harder does nothing, but building total-body strength (which grip reflects) does. Excellent for risk stratification and monitoring.
VO2max Testing
Unlike many longevity biomarkers, VO2max is both a top-tier predictor and directly, provably improvable through exercise, making it one of the most actionable diagnostics available. The main caveat is that consumer-wearable VO2max estimates are only rough approximations of a lab CPET.